The estimated Net Worth of Julie A Hill is at least $17.9 Миллион dollars as of 20 May 2021. Ms. Hill owns over 1,308 units of Anthem Inc stock worth over $15,062,770 and over the last 21 years she sold ANTM stock worth over $2,454,484. In addition, she makes $371,383 as Independent Director at Anthem Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Hill ANTM stock SEC Form 4 insiders trading
Julie has made over 10 trades of the Anthem Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently she sold 1,308 units of ANTM stock worth $515,352 on 20 May 2021.
The largest trade she's ever made was selling 1,656 units of Anthem Inc stock on 26 July 2019 worth over $488,520. On average, Julie trades about 428 units every 69 days since 2004. As of 20 May 2021 she still owns at least 31,213 units of Anthem Inc stock.
You can see the complete history of Ms. Hill stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Julie Hill biography
Julie A. Hill is Independent Director of Anthem, Inc. Ms. Hill served on the former WellPoint Health Networks Inc. (“WHN”) board of directors from March 1994 until WHN’s merger with us in November 2004. Since 2002, she has been the owner of The Hill Company (real estate company). From 1998 to 2002, Ms. Hill was the President and owner of Hiram-Hill Development Company (residential real estate development firm). Prior thereto, she was the Chairman, President and Chief Executive Officer of Costain Homes, Inc. (home builders), the U.S. division of Costain Group Plc, a London-based company, from 1988 to 1997. Ms. Hill has served as a director of the Lord Abbett Family of Mutual Funds (mutual funds) since 2005 and previously served as a director of UNYQ (provider of orthopedic devices) from 2017 until 2019. She is chair of the University of California at Irvine Board of Trustees and serves as a member of the advisory boards of the Paul Merage School of Business Center for Real Estate, the UC Irvine School of Law Board of Visitors, the School of Social Ecology Dean’s Leadership Council, the Susan Samueli Center of Integrative Medicine, and the Paul Merage School of Business Center for Digital Transformation.
What is the salary of Julie Hill?
As the Independent Director of Anthem Inc, the total compensation of Julie Hill at Anthem Inc is $371,383. There are 13 executives at Anthem Inc getting paid more, with Gail Boudreaux having the highest compensation of $15,473,100.
How old is Julie Hill?
Julie Hill is 73, she's been the Independent Director of Anthem Inc since 2004. There are no older and 24 younger executives at Anthem Inc.
Insiders trading at Anthem Inc
Over the last 10 years, insiders at Anthem Inc have traded over $153,319,533 worth of Anthem Inc stock and bought 10,600 units worth $3,007,039 . The most active insiders traders include Antonio F Neri, Ryan M. Schneider и Lewis Iii Hay. On average, Anthem Inc executives and independent directors trade stock every 21 days with the average trade being worth of $5,250,953. The most recent stock trade was executed by Charles Morgan Jr Kendrick on 9 June 2022, trading 6,328 units of ANTM stock currently worth $1,806,771.
What does Anthem Inc do?
Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately 43 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner.
What does Anthem Inc's logo look like?
Complete history of Ms. Hill stock trades at Resources Connection Inc и Anthem Inc
Anthem Inc executives and stock owners
Anthem Inc executives and other stock owners filed with the SEC include:
-
Gail Boudreaux,
President, Chief Executive Officer, Director -
Felicia Norwood,
Executive Vice President, President - Government Business Division -
Gloria McCarthy,
Executive Vice President, Chief Administrative Officer -
Gail Koziara Boudreaux,
Pres, CEO & Director -
John Gallina,
Chief Financial Officer, Executive Vice President -
Peter Haytaian,
Executive Vice President, President of Commercial and Specialty Business Division -
Thomas Zielinski,
Executive Vice President, General Counsel -
John Edward Gallina,
Exec. VP & CFO -
Gloria Marie McCarthy,
Exec. VP and Chief Admin. Officer -
Peter David Haytaian Esq.,
Exec. VP and Pres of Diversified Bus. & IngenioRx -
Felicia Farr Norwood,
Exec. VP & Pres of Gov. Bus. Division -
Elizabeth Tallett,
Independent Chairman of the Board -
Ramiro Peru,
Independent Director -
Julie Hill,
Independent Director -
Robert Dixon,
Independent Director -
Lewis Hay,
Independent Director -
R. Kerry Clark,
Independent Director -
Antonio Neri,
Independent Director -
Bahija Jallal,
Independent Director -
Ryan Schneider,
Independent Director -
Chris Rigg,
Vice President Investor Relations -
Ronald Penczek,
Senior Vice President, Chief Accounting Officer, Controller -
Prakash Patel,
Executive Vice President, President - Diversified Business Group -
Leah Stark,
Chief Human Resource Officer, Executive Vice President -
Stephen Vartan Tanal C.F.A.,
VP of Investor Relations -
Thomas H. Miller,
Sr. VP & Chief Information Officer -
Anil Bhatt,
Chief Technology Officer -
Ronald William Penczek,
Sr. VP, Controller & Chief Accounting Officer -
Scott Wayne Anglin,
SVP, Treasurer & Chief Investment Officer -
Joseph Swedish,
President & CEO -
William J Ryan,
Director -
George A Jr Schaefer,
Director -
Jose D. Tomas,
EVP & Chief HR Officer -
Jacquelyn H Wolf,
EVP & Chief HR Officer -
Craig E Samitt,
EVP & Chief Clinical Officer -
Wayne S De Veydt,
EVP & Chief Financial Officer -
Brian T Griffin,
EVP & President, CSBD -
Samuel R Md Nussbaum,
EVP & Chief Medical Officer -
Martin B Silverstein,
EVP & Chief Strategy Officer -
Kenneth R Goulet,
EVP, Commercial & Specialty -
Blair Williams Todt,
EVP and Chief Legal Officer -
Jeffrey D. Alter,
EVP, IngenioRx & Anthem Health -
Susan D. De Vore,
Director -
Charles Morgan Jr Kendrick,
EVP & President, Commercial